首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta.
【2h】

Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta.

机译:淋巴瘤样丘疹和地衣糠疹和糠疹的免疫组织化学区分。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lymphomatoid papulosis (LyP) and pityriasis lichenoides et varioliformis acuta (PLEVA) are benign self-healing cutaneous eruptions that may be clinically and histologically similar. However LyP has a 5% to 20% risk of associated lymphoid malignancy, whereas PLEVA does not. To determine whether the immunophenotype of lymphoid cells is useful in the distinction of these two disorders, the pattern of expression of lymphoid cell lineage and activation antigens in nine cases of LyP and seven cases of PLEVA were compared. In all cases of LyP most larger cells expressed the activation antigen Ki-1 (CD30) and lacked expression of the T-cell antigen CD7 and at least one other T-cell antigen (CD2, CD3, CD5). In contrast, CD30-antigen expression was rare or absent in PLEVA, CD3- and CD7-antigen expression was found in all cases, and diminished expression of T-cell antigens (CD2 and CD5) was seen in only one case. Diffuse expression of HLA-DR antigen by epidermal keratinocytes was found in a greater proportion of PLEVA cases (6 of 7) than LyP cases (3 of 6). In addition, CD8+ cells predominated at the dermal/epidermal junction in 3 of 6 cases of PLEVA but in only 1 of 7 cases of LyP. We conclude that LyP and PLEVA can be distinguished immunohistochemically in most, if not all, cases. Furthermore these results suggest that LyP and PLEVA are separate disorders, thus accounting for their variable prognoses.
机译:淋巴瘤样丘疹性病变(LyP)和皮肤性糠疹性糠疹和皮肤变应性皮疹(PLEVA)是良性的自愈性皮肤爆发,在临床和组织学上可能相似。然而,LyP具有相关淋巴恶性肿瘤的5%至20%的风险,而PLEVA则没有。为了确定淋巴样细胞的免疫表型是否可用于区分这两种疾病,比较了9例LyP和7例PLEVA的淋巴样细胞谱系和激活抗原的表达方式。在LyP的所有情况下,大多数较大的细胞均表达激活抗原Ki-1(CD30),而缺乏T细胞抗原CD7和至少一种其他T细胞抗原(CD2,CD3,CD5)的表达。相反,在PLEVA中CD30抗原的表达很少或不存在,在所有情况下都发现CD3和CD7抗原的表达,仅在一种情况下T细胞抗原(CD2和CD5)的表达减少。与LyP病例(6分之3)相比,PLEVA病例(7分之6)发现表皮角质形成细胞扩散表达HLA-DR抗原。此外,CD8 +细胞在6例PLEVA中有3例在真皮/表皮交界处占优势,但在7例LyP中只有1例。我们得出结论,在大多数(如果不是全部)情况下,可以通过免疫组织化学方法区分LyP和PLEVA。此外,这些结果表明,LyP和PLEVA是独立的疾病,因此可以解释其可变的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号